Increasingly patients are learning about Wegovy and other GLP-1 therapies due to their apparent impact in weight loss . First intended to treat diabetes , these GLP-1 receptor agonists function by imitating a inherent hormone that controls food intake and slows gastric motility . This two-pronged approach can result in substantial weight reduction